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Identification of Bacterial Muramyl Dipeptide
as Activator of the NALP3/Cryopyrin Inflammasome
bacterial products, leading to the activation of cas-
pase-1 independent of TLRs.
In order to test this hypothesis, we added crude prep-
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University of Lausanne arations of LPS (LPSc) or ATP, which is another well-
known stimulus, to the monocytic cell line THP-1 (Fig-Chemin des Boveresses 155
CH-1066 Epalinges ures 1A and 1B). Intracellular processing of proIL-1 to
the active p17 fragment occurred in cells within 1 hr,Switzerland
followed by the release of the active cytokine after 2–3
hr. To our surprise, however, highly purified E. coli LPS
(LPSp) did not stimulate IL-1 processing and secretion
(Figures 1A and 1B). The trivial explanation that LPSp
Summary was inactive was ruled out because addition of LPSp
to mouse embryonic fibroblasts resulted in the robust
Activation of caspase-1 and subsequent processing phosphorylation of the inhibitor of NF-B, I-B, and
and secretion of the pro-inflammatory cytokine IL-1 phosphorylation (activation) of extracellular signal-regu-
is triggered upon assembly of the inflammasome com- lated kinases (ERK) in a time-dependent manner (Figure
plex [1]. It is generally believed that bacterial lipopoly- 1C). Therefore, we suspected that the active component
saccharides (LPS) are activators of the inflammasome triggering IL-1 maturation was not LPS but a contami-
through stimulation of Toll-like receptor 4 (TLR4) [2]. nant thereof. The crude LPS mixture was therefore sepa-
Like TLRs, NALP3/Cryopyrin, which is a key compo- rated by gel-filtration chromatography. Subsequent
nent of the inflammasome [3], contains Leucine-Rich- analysis of the fractions revealed a broad peak of IL-
Repeats (LRRs). LRRs are frequently used to sense 1-processing activity, confirming the heterogeneity of
bacterial components [1, 4, 5], thus raising the possi- the preparation (Figure 2A, lower panel). A significant
bility that bacteria directly activate the inflammasome. activity eluted in low molecular weight fractions in which
Here, we show that bacterial peptidoglycans (PGN), LPS was unlikely to be present (LPS micelles elute in the
but surprisingly not LPS, induce NALP3-mediated acti- void volume fractions). This activity profile was strikingly
vation of caspase-1 and maturation of proIL-1. Acti- reminiscent of that shown for the identification of the
vation is independent of TLRs because the PGN degra- bacterial component responsible for the activation of
dation product muramyl dipeptide (MDP), which is not NOD2 [14]. NOD2 and its structural relative NOD1 are
sensed by TLRs, is the minimal-activating structure. intracellular PRR and have high structural similarity to
Macrophages from a patient with Muckle-Wells syn- the NALPs, but their stimulation leads to the activation
drome, an autoinflammatory disease associated with of the NF-B pathway rather than to caspase-1 activa-
mutations in the NALP3/Cryopyrin gene, show in- tion [8]. Both NOD2 and NOD1 sense the presence of
creased IL-1 secretion in the presence of MDP. The bacterial PGN [14–16].
activation of the NALP3-inflammasome by MDP may Considering the structural similarity of NODs and
be the basis of the potent adjuvant activity of MDP. NALPs and the similarity of the gel-filtration activity pro-
files, we hypothesized that PGN products may also act
as a PAMP for the NALPs. The crude LPS preparationResults and Discussion
was therefore treated with mutanolysin, an enzyme that
digests PGN, but not LPS, yielding muramyl-pep-The pivotal molecules of the inflammasome are the
tides composed of N-acetylglucosamine (GlcNAc) andNALP proteins, a family of proteins encompassing 14
N-acetyl muramic acid (MurNAc) linked to small pep-members [6, 7]. NALPs contain a Pyrin domain, a NOD/
tides (Figure 2B). After gel-filtration chromatography,NACHT oligomerization domain, and LRRs. NALP1,
the IL-1-processing activity had indeed shifted andNALP2, NALP3, NALP6, and NALP12 bind and activate
eluted predominantly in two peaks with small molecularcaspase-1 via the adaptor protein ASC [3, 5, 6, 8]. Albeit
masses (Figure 2B). These results are consistent withless efficient than the NALPs, a NALP-related protein
the notion that the IL-1-activating substance is not LPScalled Ipaf has also been shown to activate caspase-1
but PGN and muropeptides thereof. Indeed, exposure[5, 9–11]. LRRs found in both the NALPs and Ipaf are
of THP-1 cells to PGN alone efficiently induced secretioninteraction domains that are frequently used in so-called
of IL-1 into the supernatant (Figure 2C), while otherpattern recognition receptors (PRR) to detect key molec-
PAMPs of TLRs such as Poly-IC (TLR3), CpG (TLR9),ular signatures of invading pathogens, i.e., pathogen-
Pam3Cys (TLR2), and Zymosan (TLR2) had no effect.associated molecular patterns (PAMPS), thereby trig-
The absence of proIL-1-processing activity ofgering the innate immune system [12]. Examples of PRR
Pam3Cys and Zymosan made it unlikely that PGN prod-are TLRs, which detect bacterial or viral products such
ucts activate caspase-1 and IL-1 by binding to TLR2.as LPS (TLR4) [13]. It was therefore possible that the
Still, in order to refute this possibility and to avoid anyLRRs of some of the NALP proteins would directly sense
contamination by other bacterial substances found in
crude polymeric PGN preparations, we used a synthetic
monomeric derivative of PGN, i.e., the muramyl-dipep-*Correspondence: jurg.tschopp@ib.unil.ch
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Figure 1. LPS Does Not Activate proIL-1
(A) Concentrations of active IL-1 in supernatants of THP-1 cells stimulated for 6 hr with ATP (5 mM), crude LPS (LPSc, 10 g/ml), and a
preparation of ultrapure LPS (LPSp) (10 g/ml) were determined by ELISA. Values represent mean of normalized data  SD of triplicate
cultures.
(B) Western blotting and an antibody (D116) that specifically recognizes processed IL-1 (p17) was used to monitor maturation of proIL-1
in cell extracts (CE) and supernatants (Sup) of THP-1 cells stimulated with either crude (LPSc) or pure preparations (LPSp) of LPS. Where
shown, cells were preincubated with zVAD-fmk.
(C) Mouse embryonic fibroblast (MEFs) were stimulated with LPSp (1 g/ml) as indicated and analyzed by Western blotting for the activation
of I-B and ERK using phospho-specific antibodies. As a loading control, GSK3- was used.
Figure 2. PGN and Muramyl-dipeptides induce IL-1 maturation
(A) Crude LPS was fractionated by gel-filtration chromatography. THP-1 cells were then treated for 3 hr with the column fractions. Active
IL-1 was measured in cell extracts (CE) or supernatants (Sup) by Western blotting as described in Figure 1.
(B) As (A), but the crude LPS was digested with mutanolysin prior to gel-filtration chromatography. Mutanolysin cleaves PGN between MurNAc
and GlnNAc as indicated in the schematic representation. The box indicates the structure of Muramyl dipeptide (MDP).
(C) THP-1 cells were treated with crude LPS (10 g/ml), LPSp (10 g/ml), TLR9-activating CpG (200 nM), TLR3-activating Poly-IC (50 g/ml),
TLR2-activating Pam3Cys (10 g/ml), Zymosan (10 g/ml), and PGN (1 g/ml); cleaved IL-1 was subsequently determined in supernatants
as described above.
(D) The IL-1-processing activity of synthetic MDP-LD and MDP-DD was determined at various time points by monitoring the appearance of
cleaved IL-1 with the D116 antibody. Where indicated, the pan-caspase-inhibitor zVAD-fmk was added to block caspase-1.
(E) Activation of caspase-1 by MDP. Cells were incubated with biotinylated VAD-fmk (30 M) and subsequently stimulated with MDP or LPS
peparations for 2 hr. Active caspase-1 was then precipitated (P) using streptavidin beads. Precipitates and cell extracts (CE) were subsequently
analyzed for the presence of caspase-1 by Western blotting.
Activation of the Inflammasome by Muramyl Dipeptides
1931
Figure 3. Synthetic Muramyl Dipeptide Induces IL-1 Maturation and Release in Primary Human Macrophages
Primary human macrophages were exposed to ATP (5mM), crude LPS (LPSc, 10 g/ml), pure LPS (LPSp, 10 g/ml), MDP-LD ( 3g/ml), and
MDP-DD (3 g/ml) in the presence or absence of zVAD-fmk for 6 hr or as indicated. IL-1 release and processing were subsequently measured
by ELISA (A) and Western blotting using the D116 antibody specifically detecting the active fragment (p17) of IL-1 (B).
tide MurNAc-L-Ala-D-isoGln (MDP-LD) to stimulate the NALP3 gene localize to the NOD/NACHT domain
and have been shown or predicted to lead to someTHP-1 cells. Synthetic MDP-LD and pure PGN do not
activate TLR2 [14, 17, 18]. Addition of MDP-LD to THP-1 constitutive activation of IL-1 and to a hypersensitivity
to exogenous stimuli [3, 25, 26]. Macrophages from acells caused rapid processing of intracellular proIL-1,
detectable after 1 to 2 hr (Figure 2D), whereas the stereo- patient with MWS (R260W mutation) were therefore ex-
posed to MDP and the amount of processed IL-1 mea-isomer MurNAc-D-Ala-D-isoGln (MDP-DD) was inactive,
indicating specificity and independence of TLR2. Be- sured in the supernatant (Figure 4). When compared to
control macrophages and measured 2 and 6 hr poststi-cause proIL-1 maturation is dependent on caspase-1
activation, we also studied the activation of this proin- mulation, the IL-1 concentration was approximately
2-fold and 6-fold higher in supernatants of cells fromflammatory caspase. Caspase-1 activation is difficult
to detect in cell extracts because active caspase-1 is the MWS patient (Figures 4A and 4B). No difference
was observed with respect to TNF secretion (Figurerapidly secreted upon inflammasome assembly [4, 5].
Therefore, we trapped intracellular active caspase-1 by 4C), indicating that MDP-mediated TNF secretion is not
affected by NALP3 mutations.using the biotinylated pan-caspase inhibitor VAD-fmk,
which binds to active caspases. Active caspase-1 in its The above results strongly suggest that IL-1 pro-
cessing in response to MDP was triggered through acti-noncleaved form (processing is not required for initiator
caspases [19]) was detectable in cell extracts in the vation of NALPs. However, we could not formally ex-
clude the involvement of the other NOD-like proteinspresence of MDP and contaminated LPSc, but not LPSp
(Figure 2E). implicated in caspase-1 activation, such as Ipaf. To ob-
tain direct evidence that MDP can activate NALPs, weAlthough synthetic MDP-LD induced processing of
proIL-1 in the cytoplasm, subsequent release of the transfected 293T cells with all components required for
the NALP3 inflammasome assembly, i.e., NALP3, ASC,active cytokine was very inefficient in THP-1 cells (Figure
2D). Release of IL-1was only observed upon treatment caspase-1, and proIL-1. Figure 5A shows that active
IL-1 was detectable in the cytoplasm of transfectedof cells with crude preparations of LPS or PGN (Figure
2C). This finding is in agreement with the activity profile cells in the presence but not in the absence of MDP.
Processing was dependent on the presence of ASC,of fractionated LPSc (Figure 2A), where only high-molec-
ular fractions (most likely corresponding to polymeric NALP3, and caspase-1, indicating that MDP activated
the reconstituted inflammasome and not endogenousPGN) induced efficient IL-1 release. Thus, at least in
THP-1 cells, intracellular processing of proIL-1 and proteins present in nontransfected cells. As previously
shown [14], the same concentrations of MDP also ledsubsequent release appear to be two separate events.
Interestingly, these two distinct steps were not observed to the activation of NOD2 (Figure 5B). Again, only the
addition of crude but not pure LPS preparation triggeredin primary cells. When MDP was added to purified hu-
man monocytes, active IL-1was detectable in the cyto- inflammasome activation (Figures 5A and 5C).
In order to avoid spontaneous inflammasome activa-plasm as well as in the supernatant (Figures 3A and
3B). Pretreatment of cells with zVAD-fmk inhibited both tion, the LRRs of NALP3 interact with the NOD/NACHT
domain, thereby inhibiting NALP3 activation, which isprocessing and release of IL-1.
Mutations in the NOD/NACHT domain of NALP3/Cryo- independent of the presence of an activating ligand [3].
NALP3 exists in at least four isoforms, the shortest ofpyrin have been genetically associated with a broad
phenotypic spectrum of dominantly inherited autoin- which (NALP3s) is devoid of LRRs [21, 27]. Overexpres-
sion of NALP3s in 293T cells containing the other inflam-flammatory disorders, including Muckle-Wells syn-
drome (MWS), familial cold urticaria (FCU), and chronic masome components resulted in the spontaneous acti-
vation of IL-1, which was not further enhanced in theneurologic cutaneous and articular syndrome (CINCA)
[20–23]. All three disorders are characterized by recur- presence of MDP (Figure 5C), indicating that MDP-medi-
ated inflammasome activation is dependent on the LRRsrent inflammatory crises that involve fever, rash, and
arthritis [24]. The almost-20 distinct mutations found in of NALP3.
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The data presented here demonstrate that MDP is the
minimal structure that allows activation of the NALP3
inflammasome. Recently, MDP was also identified as the
minimal bacterial degradation product able to activate
NOD2 [14, 28]. MDP is present in PGN of most gram-
positive and gram-negative bacteria. Therefore, NALP3
can detect a diversity of bacteria, but how MDP activates
NALP3 (and NOD2) is currently unknown. Macrophages
contain intracellular hydrolases that digest PGN of intra-
cellular and phagocytosed bacteria, generating MDP,
amongst other products. However, activation of NALP3
ultimately depends on the capacity of PGN products to
translocate to the cytoplasm. Once cytosolic, MDP could
then interact either directly with the LRRs of NALP3 or
indirectly by means of a linker protein.
The NALP family comprises 14 members. In addition
to NALP3, we found that NALP1 and NALP2 also sense
the presence of MDP (unpublished data). NOD1, although
structurally closely related to NOD2, does not recognize
MDP but -D-iso-glutamyl diaminopimelic acid. Thus, it
is likely that not all NALPs sense MDP, considering also
that some of the NALPs are not expressed in immune
cells.
We found that pure LPS failed to induce IL-1 pro-
cessing and secretion. This was surprising as LPS is
widely used to stimulate IL-1 processing, demonstra-
ting that most commercially available LPS preparations
are not pure and must contain substantial quantities of
PGN and muramyl peptides. Interest in muramyl pep-
tides was already sparked 30 years ago by the identifica-
tion of MDP as the active component of Freund’s com-
plete adjuvant [29]. However, its mechanism of actionFigure 4. Increased IL-1Processing in Macrophages Isolated from
remained elusive. IL-1 is a major mediator of inflamma-a Muckle-Wells Patient in the Presence of MDP
tion. For this reason, IL-1 activity is tightly controlled.Macrophages from a Muckle-Wells patient carrying the R260W mu-
tation or a nonaffected donor were left unstimulated or stimulated IL-1 mRNA is absent from cells until stimulated by
with MDP for 3 and 6 hr. IL-1 present in the supernatant was signals activating NF-B. Even then, the translated pro-
measured by Western blot analysis (A) or by ELISA (B) as described tein is inactive and needs proteolytic processing. MDP,
in Figure 3. (C) Concentrations of TNF in the supernatant of MDP- as an activator of both NF-B via NOD2 and caspase-1
stimulated macrophages were determined by ELISA.
via NALPs, fulfills all the criteria required for the initiation
of an optimal innate immune response.
Figure 5. Activation of NALP3 by Synthetic MDP
(A) 293T cells were transfected with low amounts of expression plasmids encoding ASC, caspase-1, and proIL-1 (10 ng of each plasmid)
with (upper panel) or without (lower panel) a plasmid encoding NALP3 (10 ng). During transfection, the cells were exposed to crude LPS
(LPSc) (10 g/ml) or synthetic MDP (2 g/ml). 24 hr posttransfection, the presence of the active cleaved form of IL-1 in cell extracts was
determined by Western blotting.
(B) MDP-mediated stimulation of NOD2. 293T cells were transfected with NOD2 (60 ng) and a NF-B reporter gene in the presence and
absence of MDP (2 g/ml). The activity of the reporter gene was assayed 26 hr posttransfection.
(C) Processing of IL-1 in response to MDP and LPSp was compared in 293T cells that express the long form of NALP3 with 293T cells that
express the short form of NALP3 (NALP3s), which lacks the LRR.
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